Annual revenue:
$2.79B+$400.35M(+16.73%)Summary
- As of today (August 16, 2025), AMRX annual revenue is $2.79 billion, with the most recent change of +$400.35 million (+16.73%) on December 31, 2024.
- During the last 3 years, AMRX annual revenue has risen by +$700.29 million (+33.45%).
- AMRX annual revenue is now at all-time high.
Performance
AMRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$724.51M+$29.09M(+4.18%)Summary
- As of today (August 16, 2025), AMRX quarterly revenue is $724.51 million, with the most recent change of +$29.09 million (+4.18%) on June 30, 2025.
- Over the past year, AMRX quarterly revenue has increased by +$22.73 million (+3.24%).
- AMRX quarterly revenue is now -0.82% below its all-time high of $730.52 million, reached on December 31, 2024.
Performance
AMRX Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$2.85B+$22.73M(+0.80%)Summary
- As of today (August 16, 2025), AMRX TTM revenue is $2.85 billion, with the most recent change of +$22.73 million (+0.80%) on June 30, 2025.
- Over the past year, AMRX TTM revenue has increased by +$254.92 million (+9.81%).
- AMRX TTM revenue is now at all-time high.
Performance
AMRX TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AMRX Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +16.7% | +3.2% | +9.8% |
3 y3 years | +33.5% | +29.5% | +34.4% |
5 y5 years | +71.8% | +55.9% | +64.1% |
AMRX Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +33.5% | -0.8% | +32.8% | at high | +34.4% |
5 y | 5-year | at high | +71.8% | -0.8% | +55.9% | at high | +64.1% |
alltime | all time | at high | >+9999.0% | -0.8% | >+9999.0% | at high | >+9999.0% |
AMRX Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $724.51M(+4.2%) | $2.85B(+0.8%) |
Mar 2025 | - | $695.42M(-4.8%) | $2.83B(+1.3%) |
Dec 2024 | $2.79B(+16.7%) | $730.52M(+4.0%) | $2.79B(+4.2%) |
Sep 2024 | - | $702.47M(+0.1%) | $2.68B(+3.2%) |
Jun 2024 | - | $701.78M(+6.5%) | $2.60B(+4.1%) |
Mar 2024 | - | $659.19M(+6.8%) | $2.50B(+4.2%) |
Dec 2023 | $2.39B(+8.2%) | $616.98M(-0.5%) | $2.39B(+0.3%) |
Sep 2023 | - | $620.04M(+3.5%) | $2.39B(+3.2%) |
Jun 2023 | - | $599.05M(+7.4%) | $2.31B(+1.7%) |
Mar 2023 | - | $557.54M(-8.6%) | $2.27B(+2.7%) |
Dec 2022 | $2.21B(+5.7%) | $609.76M(+11.8%) | $2.21B(+3.4%) |
Sep 2022 | - | $545.56M(-2.5%) | $2.14B(+0.8%) |
Jun 2022 | - | $559.36M(+12.4%) | $2.12B(+1.2%) |
Mar 2022 | - | $497.63M(-7.3%) | $2.10B(+0.2%) |
Dec 2021 | $2.09B(+5.1%) | $536.90M(+1.6%) | $2.09B(+1.3%) |
Sep 2021 | - | $528.59M(-1.2%) | $2.07B(+0.5%) |
Jun 2021 | - | $535.08M(+8.5%) | $2.06B(+3.5%) |
Mar 2021 | - | $493.11M(-3.3%) | $1.99B(-0.3%) |
Dec 2020 | $1.99B(+22.5%) | $510.03M(-1.8%) | $1.99B(+6.0%) |
Sep 2020 | - | $519.29M(+11.8%) | $1.88B(+8.1%) |
Jun 2020 | - | $464.66M(-6.8%) | $1.74B(+3.6%) |
Mar 2020 | - | $498.53M(+25.5%) | $1.68B(+3.2%) |
Dec 2019 | $1.63B(-2.2%) | $397.33M(+5.0%) | $1.63B(-5.8%) |
Sep 2019 | - | $378.28M(-6.5%) | $1.73B(-5.4%) |
Jun 2019 | - | $404.64M(-9.3%) | $1.82B(-0.5%) |
Mar 2019 | - | $446.12M(-10.3%) | $1.83B(+10.3%) |
Dec 2018 | $1.66B(+60.9%) | $497.53M(+4.4%) | $1.66B(+14.0%) |
Sep 2018 | - | $476.49M(+15.2%) | $1.46B(+17.9%) |
Jun 2018 | - | $413.79M(+50.4%) | $1.24B(+14.2%) |
Mar 2018 | - | $275.19M(-6.2%) | $1.08B(+34.1%) |
Dec 2017 | $1.03B(+25.4%) | $293.37M(+15.2%) | $807.97M(+13.3%) |
Sep 2017 | - | $254.73M(-2.0%) | $713.03M(+3.9%) |
Jun 2017 | - | $259.87M(>+9900.0%) | $686.20M(+14.6%) |
Mar 2017 | - | $0.00(-100.0%) | $598.92M(-27.4%) |
Dec 2016 | $824.43M(-4.2%) | - | - |
Dec 2016 | - | $198.42M(-12.9%) | $824.43M(-9.2%) |
Sep 2016 | - | $227.91M(+32.1%) | $908.10M(+0.8%) |
Jun 2016 | - | $172.59M(-23.5%) | $901.29M(-4.4%) |
Mar 2016 | - | $225.51M(-20.1%) | $942.88M(+9.6%) |
Dec 2015 | $860.47M(+44.4%) | $282.09M(+27.6%) | $860.47M(+21.3%) |
Sep 2015 | - | $221.10M(+3.2%) | $709.59M(+9.8%) |
Jun 2015 | - | $214.18M(+49.7%) | $646.49M(+4.2%) |
Mar 2015 | - | $143.10M(+9.1%) | $620.43M(+4.1%) |
Dec 2014 | $596.05M(+16.5%) | $131.21M(-17.0%) | $596.05M(+5.4%) |
Sep 2014 | - | $158.00M(-16.0%) | $565.58M(+4.7%) |
Jun 2014 | - | $188.12M(+58.5%) | $540.22M(+12.1%) |
Mar 2014 | - | $118.72M(+17.8%) | $481.73M(-5.8%) |
Dec 2013 | $511.50M(-12.1%) | $100.74M(-24.0%) | $511.50M(-7.3%) |
Sep 2013 | - | $132.64M(+2.3%) | $551.84M(-2.3%) |
Jun 2013 | - | $129.63M(-12.7%) | $564.78M(-6.1%) |
Mar 2013 | - | $148.49M(+5.3%) | $601.61M(+3.4%) |
Dec 2012 | $581.69M | $141.08M(-3.1%) | $581.69M(-2.9%) |
Sep 2012 | - | $145.59M(-12.5%) | $599.17M(+4.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2012 | - | $166.46M(+29.5%) | $573.44M(+7.6%) |
Mar 2012 | - | $128.57M(-18.9%) | $532.84M(+3.9%) |
Dec 2011 | $512.92M(-41.7%) | $158.56M(+32.3%) | $512.92M(+13.1%) |
Sep 2011 | - | $119.85M(-4.8%) | $453.46M(-28.9%) |
Jun 2011 | - | $125.86M(+15.8%) | $637.61M(-4.1%) |
Mar 2011 | - | $108.65M(+9.6%) | $664.83M(-24.4%) |
Dec 2010 | $879.51M(+145.4%) | $99.10M(-67.4%) | $879.51M(-8.1%) |
Sep 2010 | - | $303.99M(+98.6%) | $956.54M(+33.3%) |
Jun 2010 | - | $153.08M(-52.7%) | $717.50M(+15.2%) |
Mar 2010 | - | $323.33M(+83.6%) | $622.83M(+73.8%) |
Dec 2009 | $358.41M(+70.6%) | $176.13M(+171.2%) | $358.41M(+57.9%) |
Sep 2009 | - | $64.95M(+11.2%) | $226.97M(+14.2%) |
Jun 2009 | - | $58.42M(-0.8%) | $198.80M(-9.2%) |
Mar 2009 | - | $58.91M(+31.8%) | $219.05M(+4.3%) |
Dec 2008 | $210.07M(-23.3%) | $44.70M(+21.5%) | $210.07M(-9.8%) |
Sep 2008 | - | $36.77M(-53.3%) | $232.84M(-24.8%) |
Jun 2008 | - | $78.67M(+57.6%) | $309.49M(+6.7%) |
Mar 2008 | - | $49.93M(-26.0%) | $290.02M(+5.9%) |
Dec 2007 | $273.75M(+102.4%) | $67.47M(-40.5%) | $273.75M(+6.1%) |
Sep 2007 | - | $113.42M(+91.6%) | $257.94M(+46.5%) |
Jun 2007 | - | $59.20M(+75.9%) | $176.06M(+20.1%) |
Mar 2007 | - | $33.66M(-34.8%) | $146.60M(+8.4%) |
Dec 2006 | $135.25M(+20.3%) | $51.65M(+63.7%) | $135.25M(+61.8%) |
Sep 2006 | - | $31.55M(+6.1%) | $83.59M(+60.6%) |
Jun 2006 | - | $29.74M(+33.4%) | $52.05M(+133.4%) |
Mar 2006 | - | $22.30M(-27.4%) | $22.30M(-80.2%) |
Dec 2005 | $112.40M(+91.1%) | - | - |
Sep 2004 | - | $30.70M(+0.5%) | $112.64M(+14.4%) |
Jun 2004 | - | $30.56M(-11.5%) | $98.44M(+20.1%) |
Mar 2004 | - | $34.55M(+105.3%) | $81.94M(+39.3%) |
Dec 2003 | $58.82M(+139.9%) | $16.83M(+2.0%) | $58.82M(+16.7%) |
Sep 2003 | - | $16.50M(+17.3%) | $50.39M(+21.6%) |
Jun 2003 | - | $14.07M(+23.1%) | $41.43M(+27.4%) |
Mar 2003 | - | $11.43M(+36.0%) | $32.51M(+32.6%) |
Dec 2002 | $24.52M(+271.9%) | $8.40M(+11.4%) | $24.52M(+35.1%) |
Sep 2002 | - | $7.54M(+46.5%) | $18.14M(+48.0%) |
Jun 2002 | - | $5.14M(+49.9%) | $12.26M(+48.6%) |
Mar 2002 | - | $3.43M(+69.5%) | $8.25M(+25.2%) |
Dec 2001 | $6.59M(-35.2%) | $2.02M(+22.1%) | $6.59M(+12.4%) |
Sep 2001 | - | $1.66M(+46.0%) | $5.87M(-16.0%) |
Jun 2001 | - | $1.14M(-35.9%) | $6.99M(-20.2%) |
Mar 2001 | - | $1.77M(+36.3%) | $8.76M(-7.9%) |
Dec 2000 | $10.17M(+720.2%) | $1.30M(-53.2%) | $9.50M(+15.8%) |
Sep 2000 | - | $2.78M(-4.5%) | $8.20M(+0.5%) |
Jun 2000 | - | $2.91M(+15.5%) | $8.16M(+6.8%) |
Mar 2000 | - | $2.52M(>+9900.0%) | $7.65M(+9.9%) |
Dec 1999 | $1.24M(-71.8%) | $0.00(-100.0%) | $6.96M(-15.3%) |
Sep 1999 | - | $2.74M(+14.6%) | $8.21M(+22.5%) |
Jun 1999 | - | $2.39M(+30.8%) | $6.70M(+25.7%) |
Mar 1999 | - | $1.83M(+45.8%) | $5.33M(+21.1%) |
Dec 1998 | $4.40M | $1.25M(+1.9%) | $4.40M(+39.8%) |
Sep 1998 | - | $1.23M(+20.6%) | $3.15M(+64.1%) |
Jun 1998 | - | $1.02M(+13.6%) | $1.92M(+113.6%) |
Mar 1998 | - | $898.00K | $898.00K |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual revenue?
- What is the all time high annual revenue for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual revenue year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly revenue?
- What is the all time high quarterly revenue for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly revenue year-on-year change?
- What is Amneal Pharmaceuticals, Inc. TTM revenue?
- What is the all time high TTM revenue for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. TTM revenue year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual revenue?
The current annual revenue of AMRX is $2.79B
What is the all time high annual revenue for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual revenue is $2.79B
What is Amneal Pharmaceuticals, Inc. annual revenue year-on-year change?
Over the past year, AMRX annual revenue has changed by +$400.35M (+16.73%)
What is Amneal Pharmaceuticals, Inc. quarterly revenue?
The current quarterly revenue of AMRX is $724.51M
What is the all time high quarterly revenue for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly revenue is $730.52M
What is Amneal Pharmaceuticals, Inc. quarterly revenue year-on-year change?
Over the past year, AMRX quarterly revenue has changed by +$22.73M (+3.24%)
What is Amneal Pharmaceuticals, Inc. TTM revenue?
The current TTM revenue of AMRX is $2.85B
What is the all time high TTM revenue for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high TTM revenue is $2.85B
What is Amneal Pharmaceuticals, Inc. TTM revenue year-on-year change?
Over the past year, AMRX TTM revenue has changed by +$254.92M (+9.81%)